Crossen P E, Morrison M J, Colls B M
Cytogenetic and Molecular Oncology Unit, Christchurch Hospital, New Zealand.
Br J Cancer. 1994 Apr;69(4):759-61. doi: 10.1038/bjc.1994.143.
We studied 100 patients with non-Hodgkin's lymphoma, 44 patients with Hodgkin's disease and 100 controls for the prevalence of the EcoRI restriction fragment polymorphism of the L-myc oncogene. No difference in the frequency of the three genotypes (LL, LS, SS) was found between the patient and control groups. However, the S allele was found to occur more frequently in the non-Hodgkin's lymphoma patients (chi 2 = 4.57, P = 0.032). These data confirm an earlier report and suggest that the presence of the S allele is associated with susceptibility to non-Hodgkin's lymphoma.
我们研究了100例非霍奇金淋巴瘤患者、44例霍奇金病患者以及100名对照者,以了解L-myc癌基因EcoRI限制性片段多态性的流行情况。患者组和对照组之间未发现三种基因型(LL、LS、SS)的频率存在差异。然而,发现S等位基因在非霍奇金淋巴瘤患者中出现的频率更高(卡方 = 4.57,P = 0.032)。这些数据证实了先前的一份报告,并表明S等位基因的存在与非霍奇金淋巴瘤的易感性有关。